About Instituto Jalisciense de Investigacion en Diabetes y Obesida
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Instituto Jalisciense de Investigacion en Diabetes y Obesida
During the past decade, Instituto Jalisciense de Investigacion en Diabetes y Obesida conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 2 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Immunic AG"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Instituto Jalisciense de Investigacion en Diabetes y Obesida
According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are
"Type 2 Diabetes Mellitus" (3 trials), "COVID-19" (2 trials), "Type 2 Diabetes" (2 trials), "Multiple Sclerosis" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" in a lesser frequency.
Clinical Trials Intervention Types at Instituto Jalisciense de Investigacion en Diabetes y Obesida
Most popular intervention types in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Drug" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tirzepatide" (5 trials), "PF-07321332" (2 trials), "Placebo" (2 trials), "Ritonavir" (2 trials) and "Diet" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto Jalisciense de Investigacion en Diabetes y Obesida
The vast majority of trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are
10 trials for "All" genders.
Clinical Trials Status at Instituto Jalisciense de Investigacion en Diabetes y Obesida
Currently, there are NaN active trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Instituto Jalisciense de Investigacion en Diabetes y Obesida,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Jalisciense de Investigacion en Diabetes y Obesida, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".